Olga V. Razorenova
Biography
Olga V. Razorenova, Ph.D., is Associate Professor (with tenure) in the Department of Molecular Biology and Biochemistry at the University of California, Irvine. A cancer biologist focused on tumor progression and metastasis, Razorenova studies the mechanisms by which the hypoxic tumor microenvironment drives metastatic signaling, with particular emphasis on Triple Negative Breast Cancer and VHL-deficient clear cell renal cell carcinoma. Her laboratory identified the cell surface protein CDCP1 as a hypoxia-regulated driver of cancer cell migration and invasion, and she has developed a parallel research program applying synthetic lethality strategies to discover therapeutics that selectively target VHL tumor suppressor-deficient cancers.
Razorenova completed postdoctoral training in the Department of Radiation Oncology at Stanford University School of Medicine under Dr. Amato J. Giaccia, where she established the role of CDCP1 in renal cancer progression and conducted synthetic lethality screens in VHL-deficient clear cell renal cell carcinoma. She joined the faculty at UC Irvine in 2012 and was granted tenure in 2018. Her research has been supported by the American Cancer Society, the National Cancer Institute, the California Breast Cancer Research Program, and other national and private funders.
Razorenova received her Ph.D. in Molecular Biology/Cancer Biology from the Engelhardt Institute of Molecular Biology in Moscow, Russia. She has authored more than 40 peer-reviewed publications and holds a patent in cancer therapeutics filed through Stanford University. In addition to her research program, she teaches cancer biology courses at both the undergraduate and graduate levels at UC Irvine and has served as an active reviewer for NCI study sections and numerous peer-reviewed journals.
Return to topEducation
- MS in Genetics/Molecular Genetics, Lomonosov Moscow State University, 2000
- PhD in Molecular Biology/Cancer Biology, Engelhardt Institute of Molecular Biology, 2006
Distinctions
- Radiation Sciences Postdoctoral Training Program Fellowship, 2011-2012
- American Cancer Society Research Scholar Award, 2018-2021
- Elsa U. Pardee Foundation Award, 2023
- Concern Foundation CONquer CanCER Now Award, 2016-2019
- Kure It Cancer Foundation Award, 2017-2019
- California Breast Cancer Research Program Award, 2019-2022
- Travel Fellowship, Helena Anna Henzl-Gabor Young Women in Science, 2011
- Honors Diploma and gold medal, Lomonosov Moscow State University, 2000
- UCI ADVANCE Career Development Award, 2015
Areas of Expertise
- Tumor Progression and Metastasis
- Hypoxia Inducible Factor Signaling
- VHL Tumor Suppressor Pathways
- p53 Transcriptional Activity
- CDCP1-Driven Mitochondrial Metabolism
- Cancer Stem Cell Lineage Tracing
- CDK Synthetic Lethality Therapeutics
Recent Publications
- Woytash J.A., LeFebvre A.E.Y.T., Zhang Z., Xu B., Harchenko S.A., Le H.T., McColloch A.R., Shi X., Digman M.A., Razorenova O.V., “CDCP1/mitochondrial Src axis increases electron transport chain function to promote metastasis in triple-negative breast cancer” (opens in new tab), British Journal of Cancer, vol. 133, pp. 1265-1277, 2025.
- Naciri I., Liang M., Yang Y., Karner H., Lin B., De Lourdes Andrade Ludena M., Hanse E., Lebron A., Razorenova O.V., Nicholas D., Kong M., Sun S., “Loss of XIST lncRNA unlocks stemness and cellular plasticity in ovarian cancer” (opens in new tab), Proceedings of the National Academy of Sciences of the United States of America, vol. 121, no. 47, 2024.
- Yim I.S., Bandelj N., Razorenova O.V., Wang P., “Writing communities to (re-) engage faculty: The U See I Write Initiative”, To Improve the Academy: A Journal of Educational Development, vol. 42, no. 2, 2023.
- Nelson L.J., Castro K.E., Xu B., Li J., Dinh N.B., Thompson J.M., Woytash J., Kipp K.R., Razorenova O.V., “Synthetic lethality of cyclin-dependent kinase inhibitor Dinaciclib with VHL-deficiency allows for selective targeting of clear cell renal cell carcinoma” (opens in new tab), Cell Cycle, vol. 21, no. 10, pp. 1103-1119, 2022.
- Pollan S.G., Teng P.C., Jan Y.J., Livingstone J., Huang C., Kim M., Mariscal J., Rodriguez M., Chen J.F., You S., DiVizio D., Boutros P.C., Chan K.S., Rasorenova O., Cress A., Spassov D., Moasser M., Posadas E.M., Freedland S.J., Freeman M.R., et al., “Loss of CDCP1 triggers FAK activation in detached prostate cancer cells”, American Journal of Clinical and Experimental Urology, vol. 9, no. 4, pp. 350-366, 2021.
- Thompson J.M., Landman J., Razorenova O.V., “Targeting the RhoGTPase/ROCK pathway for the treatment of VHL/HIF pathway-driven cancers” (opens in new tab), Small GTPases, vol. 11, no. 1, pp. 32-38, 2020.
- Nelson L.J., Wright H.J., Dinh N.B., Nguyen K.D., Razorenova O.V., Heinemann F.S., “Src Kinase Is Biphosphorylated at Y416/Y527 and Activates the CUB-Domain Containing Protein 1/Protein Kinase C δ Pathway in a Subset of Triple-Negative Breast Cancers” (opens in new tab), American Journal of Pathology, vol. 190, no. 2, pp. 484-502, 2020.
- Vargas R., Duong V., Han H., Ta A.P., Chen Y., Zhao S., Yang B., Seo G., Chuc K., Oh S., Ali A.E., Razorenova O.V., Chen J., Luo R., Li X., Wang W., “Elucidation of WW domain ligand binding specificities in the Hippo pathway reveals STXBP4 as YAP inhibitor” (opens in new tab), EMBO Journal, vol. 39, no. 1, pp. e102406, 2020.
- Joshi K., Javani A., Park J., Velasco V., Xu B., Razorenova O., Esfandyarpour R.A., “Machine Learning-Assisted Nanoparticle-Printed Biochip for Real-Time Single Cancer Cell Analysis” (opens in new tab), Advanced Biosystems, vol. 4, no. 11, pp. e2000160, 2020.
- Thompson J.M., Alvarez A., Singha M.K., Pavesic M.W., Nguyen Q.H., Nelson L.J., Fruman D.A., Razorenova O.V., “Targeting the mevalonate pathway suppresses VHL-deficient CC-RCC through a HIF-dependent mechanism” (opens in new tab), Molecular Cancer Therapeutics, vol. 17, no. 8, pp. 1781-1792, 2018.
- Thompson J.M., Nguyen Q.H., Singh M., Pavesic M.W., Nesterenko I., Nelson L.J., Liao A., Razorenova O.V., “Rho-Associated Kinase 1 inhibition is synthetically lethal with von Hippel Lindau deficiency in clear cell renal cell carcinoma” (opens in new tab), Oncogene, vol. 36, no. 8, pp. 1080-1089, 2017.
- Castellini L., Krieg A.J., Razorenova O.V., Giaccia A.J., “KDM4B/JMJD2B is a p53 target gene that modulates the amplitude of p53 response after DNA damage” (opens in new tab), Nucleic Acids Research, vol. 45, no. 7, pp. 3674-3692, 2017.
- Hou J., Wright H.J., Chan N., Tran R., Razorenova O.V., Potma E.O., Tromberg B.J., “Correlating two-photon excited fluorescence imaging of breast cancer cellular redox state with seahorse flux analysis of normalized cellular oxygen consumption” (opens in new tab), Journal of Biomedical Optics, vol. 21, no. 6, pp. 60503, 2016.
- Wright H.J., Arulmoli J., Motazedi M., Nelson L.J., Heinemann F.S., Flanagan L.A., Razorenova O.V., “CDCP1 cleavage is necessary for homodimerization-induced migration of triple-negative breast cancer” (opens in new tab), Oncogene, vol. 35, no. 36, pp. 4762-4772, 2016.
- Wright H.J., Police A.M., Razorenova O.V., “Targeting CDCP1 dimerization in Triple-Negative Breast Cancer” (opens in new tab), Cell Cycle, vol. 15, no. 18, pp. 2385-6, 2016.
- Hou J., Wright H.J., Chan N., Tran R., Razorenova O.V., Potma E.O., Tromberg B.J., “Two-photon excited fluorescence imaging and oxygen flux analysis of optical redox ratios in breast cancer cells” (opens in new tab), Optics Infobase Conference Papers, 2016.
- Thompson J.M., Nguyen Q.N., Singh M., Razorenova O.V., “Approaches to identifying synthetic lethal interactions in cancer”, Yale Journal of Biology and Medicine, vol. 88, no. 2, pp. 145-155, 2015.
- Razorenova O.V., Castellini L., Colavitti R., Edgington L.E., Nicolau M., Huang X., Bedogni B., Mills E.M., Bogyo M., Giaccia A.J., “The apoptosis repressor with a CARD domain (ARC) gene is a direct hypoxia-inducible factor 1 target gene and promotes survival and proliferation of VHL-deficient renal cancer cells” (opens in new tab), Molecular and Cellular Biology, vol. 34, no. 4, pp. 739-51, 2014.
- Razorenova O.V., “Brain and Muscle ARNT-Like protein BMAL1 regulates ROS homeostasis and senescence: a possible link to Hypoxia Inducible Factor mediated pathway” (opens in new tab), Cell Cycle, vol. 11, no. 2, pp. 213-214, 2012.
- Razorenova O.V., Finger E., Colavitti R., Chernikova S.B., Boiko A.D., Chan C., Krieg A.J., Bedogni B., LaGory E., Weissman I.L., Broome-Powell M., Giaccia A.J., “VHL loss in renal cell carcinoma leads to HIF-dependent upregulation of CUB domain-containing protein 1 to stimulate PKCδ-driven migration” (opens in new tab), Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 5, pp. 1931-1936, 2011.
Most Cited Publications
- Boiko A.D., Razorenova O.V., van de Rijn M., Swetter S.M., Johnson D.L., Ly D.P., Butler P.D., Yang G.P., Joshua B., Kaplan M.J., Longaker M.T., Weissman I.L., “Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271” (opens in new tab), Nature, vol. 466, pp. 133-137, 2010.
- Chen J., Somanath P.R., Razorenova O., Chen W.S., Hay N., Bornstein P., Byzova T.V., “Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo” (opens in new tab), Nature Medicine, vol. 11, no. 11, pp. 1188-1196, 2005.
- Krieg A.J., Rankin E.B., Chan D., Razorenova O., Fernandez S., Giaccia A.J., “Regulation of the Histone Demethylase JMJD1A by HIF-1α Enhances Hypoxic Gene Expression and Tumor Growth” (opens in new tab), Molecular and Cellular Biology, vol. 30, no. 1, pp. 344-353, 2009.
- Malinin N.L., Zhang L., Choi J., Ciocea A., Razorenova O., Ma Y.Q., Podrez E.A., Tosi M., Lennon D.P., Caplan A.I., Shurin S.B., Plow E.F., Byzova T.V., “A point mutation in KINDLIN3 ablates activation of three integrin subfamilies in humans” (opens in new tab), Nature Medicine, vol. 15, no. 3, pp. 313-318, 2009.
- Somanath P.R., Razorenova O.V., Chen J., Byzova T.V., “Role for Akt1 kinase in angiogenesis and endothelial cell biology” (opens in new tab), Cell Cycle, vol. 5, no. 5, pp. 512-518, 2006.
- Wright H.J., Hou J., Xu B., Cortez M., Potma E.O., Tromberg B.J., Razorenova O.V., “CDCP1 drives triple-negative breast cancer metastasis through reduction of lipid droplet abundance and stimulation of fatty acid oxidation” (opens in new tab), Proceedings of the National Academy of Sciences of the United States of America, vol. 114, no. 32, pp. E6556-E6565, 2017.
- Arulmoli J., Wright H.J., Phan D.T., Sheth U., Que R.A., Botten G.A., Keating M., Botvinick E.L., Pathak M.M., Zarembinski T.I., Yanni D.S., Razorenova O.V., Hughes C.C., Flanagan L.A., “Combination scaffolds of salmon fibrin, hyaluronic acid, and laminin for human neural stem cell and vascular tissue engineering” (opens in new tab), Acta Biomaterialia, vol. 43, pp. 122-138, 2016.
- De S., Razorenova O., McCabe N.P., O'Toole T.E., Qin J., Byzova T.V., “VEGF–integrin interplay controls tumor growth and vascularization” (opens in new tab), Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 21, pp. 7589-7594, 2005.
- Boiko A.D., Porteous S., Razorenova O.V., Krivokrysenko V.I., Williams B., Gudkov A.V., “A systematic search for downstream mediators of tumor suppressor function of p53 reveals a major role of BTG2 in suppression of Ras-induced transformation” (opens in new tab), Genes and Development, vol. 20, no. 2, pp. 236-252, 2006.
- Chernikova S.B., Razorenova O.V., Higgins J., Sishc B.J., Nicolau M., Dorth J.A., Chernikova D.A., Kwok S., Brooks J.D., Bailey S.M., Game J.C., Brown J.M., “Deficiency in mammalian histone H2B ubiquitin ligase Bre1 (Rnf20/Rnf40) leads to replication stress and chromosomal instability” (opens in new tab), Cancer Research, vol. 72, no. 8, pp. 2111-9, 2012.
This profile was created with the help of AI.
Last updated on 10/16/2026.